Gurmit Grewal

482 total citations
14 papers, 361 citations indexed

About

Gurmit Grewal is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gurmit Grewal has authored 14 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Gurmit Grewal's work include Histone Deacetylase Inhibitors Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Gurmit Grewal is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Gurmit Grewal collaborates with scholars based in United States, India and Sweden. Gurmit Grewal's co-authors include Neelu Kaila, Richard W. Franck, Subban Ramesh, Ashish Thakur, Anton Simeonov, Gregory J. Tawa, Surender Kharbanda, Richard M. Stone, Xin Xu and Mark J. Henderson and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Gurmit Grewal

14 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gurmit Grewal United States	9	222	191	41	32	30	14	361
Si-Tu Xue China	13	199 0.9×	190 1.0×	78 1.9×	32 1.0×	23 0.8×	30	432
Hiroo Koyama Japan	13	252 1.1×	235 1.2×	38 0.9×	51 1.6×	40 1.3×	28	547
Shankar Jayarama India	12	224 1.0×	137 0.7×	62 1.5×	26 0.8×	18 0.6×	29	441
Zizhao Guo China	9	229 1.0×	248 1.3×	132 3.2×	24 0.8×	23 0.8×	11	403
Sevil Özcan United States	12	174 0.8×	188 1.0×	75 1.8×	38 1.2×	27 0.9×	19	402
Hemantkumar Deokar United States	11	228 1.0×	148 0.8×	60 1.5×	47 1.5×	67 2.2×	20	380
Fatima Naaz India	8	159 0.7×	288 1.5×	37 0.9×	55 1.7×	19 0.6×	12	430
Jean‐Michel Robert France	11	169 0.8×	261 1.4×	43 1.0×	28 0.9×	23 0.8×	19	412
Changkun Hu United States	10	316 1.4×	414 2.2×	82 2.0×	35 1.1×	29 1.0×	26	691
Mickaël Jean France	12	179 0.8×	231 1.2×	48 1.2×	53 1.7×	12 0.4×	27	426

Countries citing papers authored by Gurmit Grewal

Since Specialization

Citations

This map shows the geographic impact of Gurmit Grewal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurmit Grewal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurmit Grewal more than expected).

Fields of papers citing papers by Gurmit Grewal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gurmit Grewal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurmit Grewal. The network helps show where Gurmit Grewal may publish in the future.

Co-authorship network of co-authors of Gurmit Grewal

This figure shows the co-authorship network connecting the top 25 collaborators of Gurmit Grewal. A scholar is included among the top collaborators of Gurmit Grewal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurmit Grewal. Gurmit Grewal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tiwari, Sachchidanand, Neha Mehrotra, Ashish Thakur, et al.. (2023). Quatramer™ encapsulation of dual‐targeted PI3‐Kδ / HDAC6 inhibitor, HSB ‐510, suppresses growth of breast cancer. Bioengineering & Translational Medicine. 8(5). e10541–e10541. 6 indexed citations

Tiwari, Sachchidanand, Neha Mehrotra, Ashish Thakur, et al.. (2022). Abstract 5406: Novel quatramer nano-formulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of triple negative breast cancer. Cancer Research. 82(12_Supplement). 5406–5406. 2 indexed citations

Tawa, Gregory J., John Braisted, David Gerhold, et al.. (2021). Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species. PLoS Computational Biology. 17(9). e1009450–e1009450. 14 indexed citations

Thakur, Ashish, Gregory J. Tawa, Mark J. Henderson, et al.. (2020). Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors. Journal of Medicinal Chemistry. 63(8). 4256–4292. 71 indexed citations

Huang, Ruili, Hu Zhu, Paul Shinn, et al.. (2019). The NCATS Pharmaceutical Collection: a 10-year update. Drug Discovery Today. 24(12). 2341–2349. 41 indexed citations

Hennessy, Edward J., Gurmit Grewal, Kate F. Byth, et al.. (2015). Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists. Bioorganic & Medicinal Chemistry Letters. 25(10). 2041–2045. 2 indexed citations

Hennessy, Edward J., Vibha Oza, Ammar Adam, et al.. (2015). Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. Journal of Medicinal Chemistry. 58(17). 7057–7075. 19 indexed citations

Shen, John Paul, et al.. (2014). New Financial and Research Models for Pediatric Orphan Drug Development: Focus on the NCATS TRND Program. Pharmaceutical Medicine. 28(1). 1–6. 3 indexed citations

Yang, Bin, Michelle L. Lamb, Tao Zhang, et al.. (2014). Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening. Journal of Medicinal Chemistry. 57(23). 9958–9970. 35 indexed citations

10.

Lewis, Timothy A., Joseph Eckman, James L. Ellis, et al.. (2004). 5-Lipoxygenase inhibitors with histamine H 1 receptor antagonist activity. Bioorganic & Medicinal Chemistry Letters. 14(9). 2265–2268. 27 indexed citations

11.

Lewis, Timothy A. & Gurmit Grewal. (2003). IMPROVED SYNTHESIS OF 1,3-DIAZA-6-ADAMANTANONE. Organic Preparations and Procedures International. 35(5). 524–525. 1 indexed citations

12.

Cai, Xiong, Mukund S. Chorghade, Aberra Fura, et al.. (1998). Synthesis of CMI-977, a Potent 5-Lipoxygenase Inhibitor. Organic Process Research & Development. 3(1). 73–76. 23 indexed citations

13.

Grewal, Gurmit, Neelu Kaila, & Richard W. Franck. (1992). Arylbis(arylthio)sulfonium salts as reagents for the synthesis of 2-deoxy-.beta.-glycosides. The Journal of Organic Chemistry. 57(7). 2084–2092. 65 indexed citations

14.

Ramesh, Subban, Neelu Kaila, Gurmit Grewal, & Richard W. Franck. (1990). Aureolic acid antibiotics: a simple method for 2-deoxy-.beta.-glycosidation. The Journal of Organic Chemistry. 55(1). 5–7. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact